No records
|
344 |
6602316235 |
Rianto Setiabudy |
Prof. Dr. dr. Rianto Setiabudy, SpFK |
Departemen Farmakologi dan Terapeutik |
Ilmu Kedokteran (S3) |
Melatonin effect on hypoxia inducible factor-1a and clinical response in patients with oral squamous cell carcinoma receiving neoadjuvant chemotherapy: A randomized controlled trial |
Kartini D., Taher A., Panigoro S., Setiabudy R., Jusman S., Haryana S., Murdani A., Rustamadji P., Karisyah A., Rasyid S. |
Journal of Carcinogenesis |
|
Q1 |
|
|
453 |
6602316235 |
Rianto Setiabudy |
Prof. Dr. dr. Rianto Setiabudy, SpFK |
Departemen Farmakologi dan Terapeutik |
Ilmu Kedokteran (S3) |
Tpmt genetic variability and its association with hematotoxicity in indonesian children with acute lymphoblastic leukemia in maintenance therapy |
Rosdiana D.S., Setiabudy R., Andalusia R., Gatot D., Louisa M., Bardosono S., Instiaty I. |
Pharmacogenomics and Personalized Medicine |
|
Q2 |
|
|
462 |
8521176100 |
Nafrialdi |
dr. Nafrialdi, Ph.D., SpPD |
Departemen Farmakologi dan Terapeutik |
Farmakologi Klinik (Sp-1) |
Development of a module for the prevention of nonsteroidal anti-inflammatory drugs-associated gastrointestinal adverse reactions in the elderly at a primary health center |
Siregar A.S., Werdhani R.A., Ascobat P., Nafrialdi N., Syam A.F., Hidayat R., Wangge G. |
International Journal of Risk and Safety in Medicine |
|
Q3 |
|
|
254 |
32067462200 |
Wawaimuli Arozal |
Dr. dr. Wawaimuli Arozal, M.Biomed., Pharm.D. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S2) |
Clinical characteristics of recurrent tuberculosis patients from a Jakarta hospital-based survey |
Arozal W., Diliana D., Wikanendra G.B., Purwantyastuti P., Rusli A. |
Journal of the Pakistan Medical Association |
|
Q4 |
|
|
294 |
32067462200 |
Wawaimuli Arozal |
Dr. dr. Wawaimuli Arozal, M.Biomed., Pharm.D. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S2) |
Curcumin Nanoparticle Enhances the Anticancer Effect of Cisplatin by Inhibiting PI3K/AKT and JAK/STAT3 Pathway in Rat Ovarian Carcinoma Induced by DMBA |
Sandhiutami N.M.D., Arozal W., Louisa M., Rahmat D., Wuyung P.E. |
Frontiers in Pharmacology |
1 |
Q1 |
|
|
59 |
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
Alpha-mangostin Reduces Cell Viability in Sorafenib-surviving Cells by Modulating Multiple Drug Transporters in Hepg2 Hepatocellular Carcinoma Cells |
Wangsaputra V.K., Syarinta S., Louisa M. |
Journal of Applied Pharmaceutical Science |
|
Q2 |
|
|
154 |
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
The potential of gallic acid as a radiosensitizer on human prostate cancer: A systematic review of preclinical studies |
Cahyono A.T., Louisa M., Mayang Permata T.B., Handoko, Nuryadi E., Kodrat H., Wibowo H., Hariandy Hamid A.R.A., Sekarutami S.M., Gondhowiardjo S.A. |
Malaysian Journal of Medicine and Health Sciences |
|
Q4 |
|
|
222 |
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
The effect of human immunodeficiency virus infection on adverse events during treatment of drug-resistant tuberculosis: A systematic review and meta-analysis |
Lazarus G., Tjoa K., Iskandar A.W.B., Louisa M., Sagwa E.L., Padayatchi N., Soetikno V. |
PLoS ONE |
|
Q1 |
|
|
260 |
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
Role of TGF-?1 in human breast cancer stem cells |
Hariyanto N.I., Purwandhita R.P., Syahrani R.A., Louisa M., Wanandi S.I. |
Journal of the Pakistan Medical Association |
|
Q4 |
|
|
294 |
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
Curcumin Nanoparticle Enhances the Anticancer Effect of Cisplatin by Inhibiting PI3K/AKT and JAK/STAT3 Pathway in Rat Ovarian Carcinoma Induced by DMBA |
Sandhiutami N.M.D., Arozal W., Louisa M., Rahmat D., Wuyung P.E. |
Frontiers in Pharmacology |
1 |
Q1 |
|
|